Ouro Fino Saude Animal Participacoes SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ouro Fino Saude Animal Participacoes SA with three other pharmaceutical manufacturers in Latin America: Instituto Hermes Pardini SA (2020 sales of 1.49 billion Brazilian Reals [US$279.68 million] of which 100% was auxiliary diagnostic support services), Laboratorios Richmond SACIF of ARGENTINA (6.18 billion Argentinian Pesos [US$62.74 million] of which 66% was Private Market), and Fleury SA (2.97 billion Brazilian Reals [US$556.29 million] of which 82% was Diagnostic Medicine).

Sales Analysis. During the second quarter of 2021, sales at Ouro Fino Saude Animal Participacoes SA totalled 230.98 million Brazilian Reals. This is an increase of 33.9% from the 172.54 million Brazilian Reals in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 399.77 million Brazilian Reals, which is 40.6% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Ouro Fino Saude Animal Participacoes SA were 730.11 million Brazilian Reals (US$136.68 million). This is an increase of 17.8% versus 2019, when the company's sales were 619.59 million Brazilian Reals. This was the fourth straight year of sales growth at Ouro Fino Saude Animal Participacoes SA. Sales of Internacional Operations saw an increase of 34.9% in 2020, from 64.27 million Brazilian Reals to 86.71 million Brazilian Reals.